According to Amicus Therapeutics 's latest financial reports and stock price the company's current number of shares outstanding is 295,759,435. At the end of 2023 the company had 295,759,435 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 0.29 B | 2.26% |
2022 | 0.28 B | 8.14% |
2021 | 0.26 B | 3.2% |
2020 | 0.25 B | 1.76% |
2019 | 0.25 B | 34.63% |
2018 | 0.18 B | 17.64% |
2017 | 0.16 B | 14.32% |
2016 | 0.14 B | 18.47% |
2015 | 0.11 B | 36.54% |
2014 | 86.95 M | 75.23% |
2013 | 49.62 M | 0.29% |
2012 | 49.47 M | 41.45% |
2011 | 34.97 M | 26.62% |
2010 | 27.62 M | 22.12% |
2009 | 22.62 M | 0.46% |
2008 | 22.51 M | 1.01% |
2007 | 22.29 M | 2928.92% |
2006 | 0.73 M | 79.41% |
2005 | 0.41 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Novo Nordisk NVO | 4,476,900,000 | 1,413.70% | ๐ฉ๐ฐ Denmark |
Biogen BIIB | 144,800,000 | -51.04% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | 2,028,000,000 | 585.69% | ๐ฌ๐ง UK |
Lexicon Pharmaceuticals
LXRX | 244,925,000 | -17.19% | ๐บ๐ธ USA |
Esperion Therapeutics ESPR | 111,869,478 | -62.18% | ๐บ๐ธ USA |
BioMarin Pharmaceutical BMRN | 188,219,000 | -36.36% | ๐บ๐ธ USA |